Sunovion Pharmaceuticals Business Systems Analyst Salaries in Wilmington, DE
The average Sunovion Pharmaceuticals Business Systems Analyst in Wilmington, DE earns an estimated $74,431 annually, which includes an estimated base salary of $72,431 with a $2,000 bonus. Sunovion Pharmaceuticals' Business Systems Analyst compensation is $9,040 less than the US average for a Business Systems Analyst. Business Systems Analyst salaries at Sunovion Pharmaceuticals in Wilmington, DE can range from $67,000 - $80,000.
In Wilmington, DE, The Operations Department at Sunovion Pharmaceuticals earns $1,129 more on average than the HR Department.
Last updated 3 years ago.
- $72,431
- avg. base
- $2,000
- avg. bonus
Business Systems Analyst Salaries at Sunovion Pharmaceuticals
In Wilmington, DE, Business Systems Analysts earn $1,321 more than Business Analysts, and $32,404 less than Operations Managers.
Compensation at Sunovion Pharmaceuticals by Department
In Wilmington, DE, The Operations Department averages $1,129 more than the HR Department, and $8,943 less than the Marketing Department
Business Systems Analyst Compensation by Gender (All Companies)
The average female Business Systems Analyst at companies similar size to Sunovion Pharmaceuticals reported making $85,427, while the average male Business Systems Analyst at similar sized companies reported making $93,384.
Business Systems Analyst Compensation by Ethnicity (All Companies)
The average Native American Business Systems Analyst at companies similar size to Sunovion Pharmaceuticals reported making $97,000, while the average African American/Black Business Systems Analyst at similar sized companies reported making $76,443.
How Business Systems Analysts at Sunovion Pharmaceuticals Rate Their Compensation
The majority of Business Systems Analysts at Sunovion Pharmaceuticals believe they're not compensated fairly. 67% of Business Systems Analysts at Sunovion Pharmaceuticals say they receive annual bonuses, and the vast majority (80%) are satisfied with their benefits. See more compensation ratings at Sunovion Pharmaceuticals
